Overview
Richard Hughes is a multi-talented health lawyer, strategic advisor, advocate, and teacher.
His thought leadership and problem-solving strategies have broken barriers to access for vaccines and medicines. His advice on legal, public affairs, and policy solutions is sought after by leading biopharmaceutical companies, industry trade associations, investors, patient advocacy organizations, members of Congress and Congressional committees, and federal agencies.
Richard's practice emphasizes vaccines, prevention, and early intervention. Health care and life sciences clients value his guidance and counsel on legal, regulatory, and policy issues, as well as his ability to assemble multidisciplinary consulting teams to offer strategic business advice and build market development strategies.
Previously, Richard served as Managing Director at a leading Washington health care advisory firm and Vice President at a major vaccine manufacturer during the COVID-19 pandemic.
Before becoming an attorney, Richard served in several health policy leadership roles. He was a gubernatorial appointee to the Arkansas State Board of Health, where he deliberated regulatory policy, presided over appeals before the state health department, and advocated for vaccine access. Richard has also held roles at the Association of State and Territorial Health Officials and with another leading biopharmaceutical company.
Outside of his practice, Richard devotes his time to teaching and mentoring students. He is a Professorial Lecturer in Law at The George Washington University Law School and previously served as a Professorial Lecturer in Health Policy & Management at the Milken Institute School of Public Health.
He publishes regularly in health law and policy journals, frequently writes commentary on Health Affairs Forefront, and is often quoted in the news media, including The New York Times, The Washington Post, NPR's Marketplace, The Hill, Politico, Forbes, Axios, Bloomberg Law, Law360, and Fierce Healthcare.
Read less
Focus Areas
Services
Recognition
- Delta Omega Honorary Society in Public Health
- Health Affairs, Top 10 Most-Read Health Affairs Blog Posts of 2019 (No. 9) (2019)
- University of Arkansas for Medical Sciences, Fay W. Boozman College of Public Health, Center Stage Alumni (2021)
Credentials
Education
- The George Washington University Law School (J.D.)
- Health Law
- University of Arkansas for Medical Sciences (M.P.H.)
- Arkansas State University (B.S.)
Professional & Community Involvement
- American Bar Association, Health Law Section
- American Health Lawyers Association
- American Journal of Public Health, Peer-Reviewer
- American Public Health Association
- American Society of Law, Medicine, and Ethics
- Arkansas State Board of Health (Gubernatorial Appointment) (2006 to 2009)
- National Vaccine Law Conference, Steering Committee
Events
Past Events
Insights
Insights
- PublicationsIs CMS Ignoring the Realities of Biopharmaceutical Costs?2 minute read
- PublicationsFederal Judge in Texas Strikes Down ACA's Preventive Services Coverage Mandate12 minute read
- PublicationsCMS Can Fix Medicare Vaccine Coverage to Protect Seniors from RSV4 minute read
- Media CoverageInsulin as Preventive Care: Why Not Eliminate Patient Cost Sharing?4 minute read
- PublicationsA Patchwork in Need of Permanent Repair: The U.S. Framework for Recommending and Covering Preventive Care2 minute read
- PublicationsReflecting on the Future of US Vaccine Programs2 minute read
- Media CoverageRichard Hughes, Spreeha Choudhury Featured in “Loosening Restrictions on Pharmacists Could Help Raise Children’s ...4 minute read
- PublicationsRecognizing Pharmacists as Vaccines for Children Providers2 minute read
- PublicationsMarking the End of an Era: The COVID-19 Vaccine Market Goes Commercial3 minute read
- PublicationsWhy Are We Delaying Coverage of New HIV Prevention?2 minute read
- PublicationsCOVID-19 Vaccine Prices Are Going Up. It Shouldn’t Be Our Focus.2 minute read
- PublicationsWill the US Supreme Court Strike Down the ACA’s Preventive Services Coverage Requirement?September 23, 20222 minute read
- PublicationsCongress Finally Eliminates Part D Vaccine Cost Sharing: Medicare Coverage Is Still BrokenAugust 26, 20223 minute read
- PublicationsCOVID-19 Vaccination and the Fetal Cell Line Conundrum for Employee Religious ObjectionsAugust 11, 202210 minute read
- PublicationsCOVID-19 Vaccine and Monoclonal Coverage: A Focus of the 2023 Medicare Physician Fee Schedule Proposed RuleAugust 1, 202210 minute read
- Media CoverageRichard Hughes’ Article on Immunization Access Cited in “A Twenty-First Century 'Vaccines for Children' Program” ...July 12, 20223 minute read
Experience
Public Policy Strategy
- Develops federal and state policy strategies for vaccine and other biopharmaceutical manufacturers, and advises clients on strategies for engaging state and federal agencies, including FDA, CDC, CMS, and BARDA.
Business Advisor
- Counsels investors and startups on market trends and developments in health care, including identifying total addressable markets. Richard also facilitates multidisciplinary expert input and advisory boards for clients.
Product Launch Advice
- Advises multiple manufacturers on launch strategy for new vaccines and other products.
- Advises novel, non-vaccine developers on strategies for obtaining a “vaccine-like” recommendation, coverage, and reimbursement pathway.
Thought Leadership
- Influences public policy development as a thought leader in the field of preventive health care and public health. Richard advised or engaged the White House, HHS, CDC, HHS, and Congressional offices on the development of vaccine policy.
Research and Analysis
- Conducted many 50-state analyses of laws, regulations, and Medicaid coverage policies, as well as payor coverage analyses. Richard led studies using survey methods and claims-based analyses of vaccine-preventable disease burden and uptake in Medicare and other markets.